MST1 and cancer: Although overexpression results have shown that nuclear MST1/2 can promote apoptosis [20–23], and reduced MST1/2 activity associates with poor cancer prognosis [24–27], the functional contributions of endogenous MST1/2 in physiological or pathological apoptosis remain elusive [19].